boehringer ingelheim glp-1 glp-1-dual-agonist-survodutide-weightloss-obesity-overweight-improvement Boehringer kickstarts two Phase III

This mimics the effects of the hormone amylin and can also slow down stomach emptying, decrease glucagon secretion after meals, and control appetite

While these agents reduce appetite, focusing on nutrient-dense, high-protein foods helps preserve muscle mass and promotes satiety

[DOI] [PMC free article] [PubMed] [Google Scholar] 200.Hudson DA, Sciascia QL, Sanders RJ, Norris GE, Edwards PJ, Sullivan PA, Farley PC

This includes guidance on nutrition, hydration, and other wellness strategies to complement your GLP-1 therapy

Effect of intraperitoneal insulin delivery on growth hormone binding protein, insulin-like growth factor (IGF)-I, and IGF-binding protein-3 in IDDM